Appreciate the response.
my view is that the recent CMS funding agreement will significantly drive revenue in the next 6 months. Furthermore ,as impressive and complimentary as Imbios offering are , functional analysis ie airflow distribution is the better/more useful metric in diseased lung analysis. Hence , I can see no time wasted in existing clients of Imbio asking for XV scans. This sugar hit of revenue plus organic growth from
new commercial agreements, make this company far less risky .
this company has hit a new chapter beyond what the tea leaves are saying!
- Forums
- ASX - By Stock
- Ann: Trading Halt
Appreciate the response.my view is that the recent CMS funding...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
(20min delay)
|
|||||
Last
44.5¢ |
Change
0.005(1.14%) |
Mkt cap ! $182.6M |
Open | High | Low | Value | Volume |
45.0¢ | 46.5¢ | 44.5¢ | $118.5K | 261.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23629 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 230601 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15393 | 0.445 |
4 | 71826 | 0.440 |
1 | 5642 | 0.435 |
5 | 41300 | 0.430 |
2 | 24964 | 0.425 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 230601 | 1 |
0.455 | 18962 | 1 |
0.470 | 29600 | 2 |
0.500 | 19555 | 2 |
0.510 | 9802 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |